✦ LIBER ✦

Rifaximin Redux: Treatment of recurrent Clostridium difficile infections with Rifaximin immediately post-vancomycin treatment

✍ Scribed by Stuart Johnson; Christopher Schriever; Ursula Patel; Toral Patel; David W. Hecht; Dale N. Gerding

Book ID: 113449731
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 109 KB
Volume: 15
Category: Article
ISSN: 1075-9964
DOI: 10.1016/j.anaerobe.2009.08.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rifaximin in the treatment of recurrent

Rifaximin in the treatment of recurrent Clostridium difficile infection

✍ Mattila, E.; Arkkila, P.; Mattila, P. S.; Tarkka, E.; Tissari, P.; Anttila, V.-J 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB

Rifaximin for the treatment of recurrent

Rifaximin for the treatment of recurrent Clostridium difficile infection after liver transplantation: A case series

✍ Guy Neff; Victoria Zacharias; Tiffany E. Kaiser; Amy Gaddis; Nyingi Kemmer 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB 👁 1 views

Previous data have suggested that the nonsystemic antibiotic rifaximin may be effective for the treatment of Clostridium difficile infection (CDI). This single-center retrospective study evaluated the efficacy of rifaximin for the treatment of CDI refractory to standard treatments in patients who ha

Treatment failure and recurrence of Clos

Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence

✍ Konstantinos Z. Vardakas; Konstantinos A. Polyzos; Konstantina Patouni; Petros I 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 309 KB

Comparison of treatment outcomes with va

Comparison of treatment outcomes with vancomycin alone versus combination therapy in severe Clostridium difficile infection

✍ Bass, S.N.; Bauer, S.R.; Neuner, E.A.; Lam, S.W. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 220 KB

Risk of Recurrence and Time to Recurrenc

Risk of Recurrence and Time to Recurrence Following Treatment of Clostridium difficile Infection: Patient Characteristics and the Differential Effect of Fidaxomicin vs. Vancomycin

✍ Golan, Yoav ;Louie, Thomas J. ;Miller, Mark ;Mullane, Kathleen M. ;Weiss, Karl ; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Mo1116 The Efficacy and Safety of Rifaxi

Mo1116 The Efficacy and Safety of Rifaximin vs. Vancomycin in the Treatment of Mild to Moderate C. difficile Infection: A Randomized Double-Blind Active Comparator Trial

✍ Pardi, Darrell S.; Brennan, Robert; Spinnell, Mitchell; Gareca, Marcelo G.; Gree 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 169 KB